Bromide

Bromide

SCHEMBL8310683

CN1CCC([P+](c2ccccc2)(c2ccccc2)c2ccccc2)C1=O.[Br-]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.35
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GRM5 P41594 3/20 0.34
BRD4 O60885 3/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7615608 0.80 HTR2B (0.33) ALDH1A1MCOLN3HPGD
Bromide SCHEMBL7622203 0.80 ALDH1A1 (0.31) KMT2AALDH1A1MCOLN3HPGD
Bromide SCHEMBL7880298 0.79 MEN1 (0.43) KMT2A
Bromide SCHEMBL7880295 0.79 MEN1 (0.43) KMT2A
Bromide SCHEMBL5198501 0.79 HSD11B1 (0.42) KMT2AALDH1A1MCOLN3
Bromide SCHEMBL5198499 0.79 HSD11B1 (0.42) KMT2AALDH1A1MCOLN3
Bromide SCHEMBL8779720 0.78 POLB (0.37) CYP2D6BRD4KMT2AALDH1A1
Bromide SCHEMBL7885589 0.77 PIK3CD (0.50) SMN1; SMN2TSHRALDH1A1MCOLN3
Bromide SCHEMBL7885592 0.77 PIK3CD (0.50) SMN1; SMN2TSHRALDH1A1MCOLN3
Bromide SCHEMBL8508757 0.76 PER2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5985905-A USEFUL FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISEASES ASSOCIATED WITH LOSS OF BONE MASS, SUCH AS OSTEOPOROSIS AND RELATED OSTEOPENIC DISEASES, PAGET'S DISEASE, HYPERPARATHYROIDISM AND RELATED DISEASES, ALSO ANTITUMOR ENCYSIVE PHARMACEUTICALS, INC. 1999-11-16 US disclosed
EP-0912560-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1999-05-06 EP disclosed
WO-1998001445-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1998-01-15 WO disclosed
EP-0204964-B1 2-PYRROLIDONE DERIVATIVES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITION AND USE Eisai Co., Ltd. (JP) 1991-08-28 EP disclosed
US-4833160-A ANTIINFLAMMATORY AGENTS, ANALGESICS EISAI CO., LTD. (JP) 1989-05-23 US disclosed
EP-0204964-A1 2-Pyrrolidone derivatives, process for preparing them, pharmaceutical composition and use Eisai Co., Ltd. (JP) 1986-12-17 EP disclosed